{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:37:22Z","timestamp":1791005842751,"version":"4.1.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1093\/neuonc\/nou329","type":"journal-article","created":{"date-parts":[[2014,12,23]],"date-time":"2014-12-23T03:02:46Z","timestamp":1419303766000},"page":"843-853","source":"Crossref","is-referenced-by-count":86,"title":["Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth"],"prefix":"10.1093","volume":"17","author":[{"given":"Aparna","family":"Kaul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Toonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Cimino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Gianino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Gutmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,12,21]]},"reference":[{"issue":"(1)","key":"key\n\t\t\t\t20170522210327_NOU329C1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jama.1997.03550010065042","article-title":"The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2","volume":"278","author":"Gutmann","year":"1997","journal-title":"JAMA"},{"issue":"(1)","key":"key\n\t\t\t\t20170522210327_NOU329C2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-3476(94)70122-9","article-title":"Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study","volume":"125","author":"Listernick","year":"1994","journal-title":"J Pediatr"},{"issue":"(5)","key":"key\n\t\t\t\t20170522210327_NOU329C3","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0022-3476(89)80137-4","article-title":"Optic gliomas in children with neurofibromatosis type 1","volume":"114","author":"Listernick","year":"1989","journal-title":"J Pediatr"},{"issue":"(3)","key":"key\n\t\t\t\t20170522210327_NOU329C4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ana.21107","article-title":"Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations","volume":"61","author":"Listernick","year":"2007","journal-title":"Ann Neurol"},{"issue":"(6)","key":"key\n\t\t\t\t20170522210327_NOU329C5","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/neuonc\/nos076","article-title":"Visual outcomes in children with neurofibromatosis type 1\u2013associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis","volume":"14","author":"Fisher","year":"2012","journal-title":"Neuro Oncol"},{"issue":"(16)","key":"key\n\t\t\t\t20170522210327_NOU329C6","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1200\/JCO.2005.03.8349","article-title":"Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy","volume":"24","author":"Sharif","year":"2006","journal-title":"J Clin Oncol"},{"issue":"(4)","key":"key\n\t\t\t\t20170522210327_NOU329C7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/neuonc\/2.4.213","article-title":"Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study","volume":"2","author":"Mahoney","year":"2000","journal-title":"Neuro Oncol"},{"issue":"(5)","key":"key\n\t\t\t\t20170522210327_NOU329C8","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1200\/JCO.1993.11.5.850","article-title":"Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood","volume":"11","author":"Packer","year":"1993","journal-title":"J Clin Oncol"},{"issue":"(1)","key":"key\n\t\t\t\t20170522210327_NOU329C9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.20337","article-title":"Natural history of neurofibromatosis 1\u2013associated optic nerve glioma in mice","volume":"57","author":"Bajenaru","year":"2005","journal-title":"Ann Neurol"},{"issue":"(24)","key":"key\n\t\t\t\t20170522210327_NOU329C10","first-page":"8573","article-title":"Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity","volume":"63","author":"Bajenaru","year":"2003","journal-title":"Cancer Res"},{"issue":"(7)","key":"key\n\t\t\t\t20170522210327_NOU329C11","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1158\/0008-5472.CAN-04-4058","article-title":"Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors","volume":"65","author":"Dasgupta","year":"2005","journal-title":"Cancer Res"},{"issue":"(1)","key":"key\n\t\t\t\t20170522210327_NOU329C12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1158\/0008-5472.236.65.1","article-title":"Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes","volume":"65","author":"Dasgupta","year":"2005","journal-title":"Cancer Res"},{"issue":"(5)","key":"key\n\t\t\t\t20170522210327_NOU329C13","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/0008-5472.CAN-07-5916","article-title":"Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma","volume":"68","author":"Hegedus","year":"2008","journal-title":"Cancer Res"},{"issue":"(1)","key":"key\n\t\t\t\t20170522210327_NOU329C14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1172\/JCI63193","article-title":"Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice","volume":"123","author":"Chang","year":"2013","journal-title":"J Clin Invest"},{"issue":"(1)","key":"key\n\t\t\t\t20170522210327_NOU329C15","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI60578","article-title":"MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors","volume":"123","author":"Jessen","year":"2013","journal-title":"J Clin Invest"},{"issue":"(2)","key":"key\n\t\t\t\t20170522210327_NOU329C16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1158\/1535-7163.MCT-11-0474","article-title":"Identification and characterization of NVP-BKM120, an orally available pan-class I PI3-kinase inhibitor","volume":"11","author":"Maira","year":"2012","journal-title":"Mol Cancer Ther"},{"issue":"(11)","key":"key\n\t\t\t\t20170522210327_NOU329C17","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/glia.20845","article-title":"Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)\u2013regulated glial proliferation","volume":"57","author":"Yeh","year":"2009","journal-title":"Glia"},{"issue":"(2)","key":"key\n\t\t\t\t20170522210327_NOU329C18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/glia.20036","article-title":"Loss of tuberous sclerosis complex 1 (Tsc1) expression results in increased Rheb\/S6 K pathway signaling important for astrocyte cell size regulation","volume":"47","author":"Uhlmann","year":"2004","journal-title":"Glia"},{"issue":"(19)","key":"key\n\t\t\t\t20170522210327_NOU329C19","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1093\/hmg\/ddn194","article-title":"Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis","volume":"17","author":"Hegedus","year":"2008","journal-title":"Hum Mol Genet"},{"issue":"(5)","key":"key\n\t\t\t\t20170522210327_NOU329C20","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/neuonc\/nou287","article-title":"The impact of coexisting genetic mutations on murine optic glioma biology","volume":"17","author":"Kaul","year":"2015","journal-title":"Neuro Oncol"},{"issue":"(2)","key":"key\n\t\t\t\t20170522210327_NOU329C21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ng0296-144","article-title":"Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells","volume":"12","author":"Bollag","year":"1996","journal-title":"Nat Genet"},{"issue":"(2)","key":"key\n\t\t\t\t20170522210327_NOU329C22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0092-8674(92)90407-4","article-title":"Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis","volume":"69","author":"DeClue","year":"1992","journal-title":"Cell"},{"issue":"(3)","key":"key\n\t\t\t\t20170522210327_NOU329C23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/onc.2012.580","article-title":"NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma","volume":"33","author":"Solga","year":"2014","journal-title":"Oncogene"},{"issue":"(Pt 1)","key":"key\n\t\t\t\t20170522210327_NOU329C24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/brain\/awg016","article-title":"Prognostic factors of CNS tumours in neurofibromatosis 1 (NF1): a retrospective study of 104 patients","volume":"126","author":"Guillamo","year":"2003","journal-title":"Brain"},{"issue":"(38)","key":"key\n\t\t\t\t20170522210327_NOU329C25","doi-asserted-by":"crossref","first-page":"15996","DOI":"10.1073\/pnas.1019012108","article-title":"Neurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC\/Rheb-independent manner","volume":"108","author":"Banerjee","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"(24)","key":"key\n\t\t\t\t20170522210327_NOU329C26","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0503224102","article-title":"The NF1 tumor suppressor critically regulates TSC2 and mTOR","volume":"102","author":"Johannessen","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"(6)","key":"key\n\t\t\t\t20170522210327_NOU329C27","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.cell.2007.03.052","article-title":"Integrative genomic approaches identify IKBKE as a breast cancer oncogene","volume":"129","author":"Boehm","year":"2007","journal-title":"Cell"},{"issue":"(7)","key":"key\n\t\t\t\t20170522210327_NOU329C28","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1158\/1535-7163.MCT-09-1012","article-title":"MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo","volume":"9","author":"Hirai","year":"2010","journal-title":"Mol Cancer Ther"},{"issue":"(1)","key":"key\n\t\t\t\t20170522210327_NOU329C29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1158\/1078-0432.CCR-11-1558","article-title":"Antitumor activity of NVP-BKM120--a selective pan class I PI3 kinase inhibitor showed differential forms of cell death based on p53 status of glioma cells","volume":"18","author":"Koul","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"(19)","key":"key\n\t\t\t\t20170522210327_NOU329C30","doi-asserted-by":"crossref","first-page":"14056","DOI":"10.1074\/jbc.M700906200","article-title":"RAS\/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation","volume":"282","author":"Roux","year":"2007","journal-title":"J Biol Chem"},{"issue":"(17)","key":"key\n\t\t\t\t20170522210327_NOU329C31","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.cub.2008.07.078","article-title":"Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation","volume":"18","author":"Carriere","year":"2008","journal-title":"Curr Biol"},{"issue":"(2)","key":"key\n\t\t\t\t20170522210327_NOU329C32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cell.2005.02.031","article-title":"Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis","volume":"121","author":"Ma","year":"2005","journal-title":"Cell"},{"issue":"(7262)","key":"key\n\t\t\t\t20170522210327_NOU329C33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nature08279","article-title":"Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras","volume":"461","author":"Lauchle","year":"2009","journal-title":"Nature"},{"issue":"(2)","key":"key\n\t\t\t\t20170522210327_NOU329C34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/pbc.24726","article-title":"Visual acuity of children treated with chemotherapy for optic pathway gliomas","volume":"61","author":"Kalin-Hajdu","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"(2)","key":"key\n\t\t\t\t20170522210327_NOU329C35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ana.24093","article-title":"Sex is a major determinant of neuronal dysfunction in neurofibromatosis type 1","volume":"75","author":"Diggs-Andrews","year":"2014","journal-title":"Ann Neurol"},{"issue":"(7)","key":"key\n\t\t\t\t20170522210327_NOU329C36","first-page":"936","article-title":"Rac1 mediates the osteoclast gains-in-function induced by haploinsufficiency of Nf1","volume":"17","author":"Yan","year":"2008","journal-title":"Hum Mol Genet"},{"issue":"(5)","key":"key\n\t\t\t\t20170522210327_NOU329C37","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/ajmg.a.33965","article-title":"Multiple increased osteoclast functions in individuals with neurofibromatosis type 1","volume":"155A","author":"Stevenson","year":"2011","journal-title":"Am J Med Genet A"},{"issue":"(1)","key":"key\n\t\t\t\t20170522210327_NOU329C38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/jor.21497","article-title":"Hyperactivation of mTOR critically regulates abnormal osteoclastogenesis in neurofibromatosis type 1","volume":"30","author":"Ma","year":"2012","journal-title":"J Orthop Res"},{"issue":"(6)","key":"key\n\t\t\t\t20170522210327_NOU329C39","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.bone.2011.09.043","article-title":"JNK inhibitors increase osteogenesis in Nf1-deficient cells","volume":"49","author":"Sullivan","year":"2011","journal-title":"Bone"},{"issue":"(24)","key":"key\n\t\t\t\t20170522210327_NOU329C40","doi-asserted-by":"crossref","first-page":"10358","DOI":"10.1158\/0008-5472.CAN-08-2506","article-title":"Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation","volume":"68","author":"Daginakatte","year":"2008","journal-title":"Cancer Res"},{"issue":"(24)","key":"key\n\t\t\t\t20170522210327_NOU329C41","doi-asserted-by":"crossref","first-page":"10420","DOI":"10.1523\/JNEUROSCI.18-24-10420.1998","article-title":"p21 ras and phosphatidylinositol-3 kinase are required for survival of wild-type and NF1 mutant sensory neurons","volume":"18","author":"Klesse","year":"1998","journal-title":"J Neurosci"},{"issue":"(16)","key":"key\n\t\t\t\t20170522210327_NOU329C42","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1523\/JNEUROSCI.3994-09.2010","article-title":"Defective cAMP generation underlies the sensitivity of CNS neurons to neurofibromatosis-1 heterozygosity","volume":"30","author":"Brown","year":"2010","journal-title":"J Neurosci"},{"issue":"(9)","key":"key\n\t\t\t\t20170522210327_NOU329C43","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1158\/1535-7163.MCT-13-0189","article-title":"NF1 deletion generates multiple subtypes of soft-tissue sarcoma that respond to MEK inhibition","volume":"12","author":"Dodd","year":"2013","journal-title":"Mol Cancer Ther"},{"issue":"(5)","key":"key\n\t\t\t\t20170522210327_NOU329C44","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1158\/1535-7163.MCT-07-2335","article-title":"Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors","volume":"7","author":"Johansson","year":"2008","journal-title":"Mol Cancer Ther"},{"issue":"(1)","key":"key\n\t\t\t\t20170522210327_NOU329C45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cub.2007.11.066","article-title":"TORC1 is essential for NF1-associated malignancies","volume":"18","author":"Johannessen","year":"2008","journal-title":"Curr Biol"},{"issue":"(6)","key":"key\n\t\t\t\t20170522210327_NOU329C46","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1535-6108(02)00214-3","article-title":"Hyperactivation of protein kinase B and ERK have discrete effects on survival, proliferation, and cytokine expression in Nf1-deficient myeloid cells","volume":"2","author":"Donovan","year":"2002","journal-title":"Cancer Cell"},{"issue":"(12)","key":"key\n\t\t\t\t20170522210327_NOU329C47","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1182\/blood-2008-04-155085","article-title":"Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+\/\u2212 mast cells","volume":"112","author":"McDaniel","year":"2008","journal-title":"Blood"},{"issue":"(1)","key":"key\n\t\t\t\t20170522210327_NOU329C48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1084\/jem.194.1.57","article-title":"Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro","volume":"194","author":"Ingram","year":"2001","journal-title":"J Exp Med"},{"issue":"(23)","key":"key\n\t\t\t\t20170522210327_NOU329C49","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1101\/gad.200907.112","article-title":"Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner","volume":"26","author":"Kaul","year":"2012","journal-title":"Genes Dev"},{"issue":"(3)","key":"key\n\t\t\t\t20170522210327_NOU329C50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jamaophthalmol.2013.7649","article-title":"Handheld optical coherence tomography during sedation in young children with optic pathway gliomas","volume":"132","author":"Avery","year":"2014","journal-title":"JAMA Ophthalmol"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/17\/6\/843\/17430306\/nou329.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T21:50:48Z","timestamp":1690753848000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-lookup\/doi\/10.1093\/neuonc\/nou329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,21]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,12,21]]},"published-print":{"date-parts":[[2015,6]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/nou329","relation":{},"ISSN":["1523-5866","1522-8517"],"issn-type":[{"value":"1523-5866","type":"electronic"},{"value":"1522-8517","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12,21]]}}}